Serial Number
97461218
Owner
CRISPR Therapeutics AGAttorney
Tiffany D. GehrkeFirst Use Date
Mar 5, 2024
Filing Date
Jun 16, 2022
CTX320 Trademark
Serial Number: 97461218 • Registration: 8137672
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Tiffany D. Gehrke MARSHALL, GERSTEIN & BORUN LLP
233 SOUTH WACKER DRIVE
6300 WILLIS TOWER
CHICAGO, IL 60606
United States
Trademark Details
Filing Date
June 16, 2022
Registration Date
February 10, 2026
First Use Anywhere
March 5, 2024
First Use in Commerce
March 5, 2024
Published for Opposition
April 23, 2024
Goods & Services
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy
Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease in the field of in vivo gene editing therapy